277 related articles for article (PubMed ID: 2909549)
21. Reflection ultrasound velocities and histomorphometric and connectivity analyses: correlations and effect of slow-release sodium fluoride.
Zerwekh JE; Antich PP; Mehta S; Sakhaee K; Gottschalk F; Pak CY
J Bone Miner Res; 1997 Dec; 12(12):2068-75. PubMed ID: 9421239
[TBL] [Abstract][Full Text] [Related]
22. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
[TBL] [Abstract][Full Text] [Related]
23. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis.
Murray TM; Ste-Marie LG
CMAJ; 1996 Oct; 155(7):949-54. PubMed ID: 8837545
[TBL] [Abstract][Full Text] [Related]
24. Measurement of intrinsic bone quality in vivo by reflection ultrasound: correction of impaired quality with slow-release sodium fluoride and calcium citrate.
Antich PP; Pak CY; Gonzales J; Anderson J; Sakhaee K; Rubin C
J Bone Miner Res; 1993 Mar; 8(3):301-11. PubMed ID: 8456586
[TBL] [Abstract][Full Text] [Related]
25. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
[TBL] [Abstract][Full Text] [Related]
26. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
[TBL] [Abstract][Full Text] [Related]
27. [Multidisciplinary study of the prolonged treatment of involution osteoporosis using sodium fluoride with calcium, phosphate and vitamin D].
Courvoisier B; Baud CA; Véry JM; Assimacopoulos A; Tochon-Danguy HJ; Boivin G; Donath A; Garcia J; Gasser A; Fischer J
Schweiz Med Wochenschr; 1985 Jul; 115(27-28):922-31. PubMed ID: 4023678
[TBL] [Abstract][Full Text] [Related]
28. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
[TBL] [Abstract][Full Text] [Related]
29. The long-term treatment of steroid osteoporosis with fluoride.
Bayley TA; Muller C; Harrison J; Basualdo J; Sturtridge W; Josse R; Murray TM; Pritzker KP; Vieth R; Goodwin S
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S157-61. PubMed ID: 2339626
[TBL] [Abstract][Full Text] [Related]
30. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
Reeve J; Davies UM; Hesp R; McNally E; Katz D
BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
[TBL] [Abstract][Full Text] [Related]
31. Anabolic effects of fluoride on bone.
Pak CY; Zerwekh JE; Antich P
Trends Endocrinol Metab; 1995 Sep; 6(7):229-34. PubMed ID: 11540313
[TBL] [Abstract][Full Text] [Related]
32. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
[TBL] [Abstract][Full Text] [Related]
33. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
Murray TM; Harrison JE; Bayley TA; Josse RG; Sturtridge WC; Chow R; Budden F; Laurier L; Pritzker KP; Kandel R
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
[TBL] [Abstract][Full Text] [Related]
34. Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
Rubin CD; Pak CY; Adams-Huet B; Genant HK; Li J; Rao DS
Arch Intern Med; 2001 Oct; 161(19):2325-33. PubMed ID: 11606148
[TBL] [Abstract][Full Text] [Related]
35. Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial.
Guañabens N; Farrerons J; Perez-Edo L; Monegal A; Renau A; Carbonell J; Roca M; Torra M; Pavesi M
Bone; 2000 Jul; 27(1):123-8. PubMed ID: 10865219
[TBL] [Abstract][Full Text] [Related]
36. Sodium fluoride in the treatment of osteoporosis.
Power GR; Gay JD
Clin Invest Med; 1986; 9(1):41-3. PubMed ID: 3955920
[TBL] [Abstract][Full Text] [Related]
37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
[TBL] [Abstract][Full Text] [Related]
40. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
